scholarly article | Q13442814 |
P356 | DOI | 10.1007/S11046-010-9322-5 |
P698 | PubMed publication ID | 20524154 |
P2093 | author name string | Ali Kaya | |
Feza Otag | |||
Gülden Ersöz | |||
Elif Sahin Horasan | |||
Ahmet Oner Kurt | |||
Musa Göksu | |||
Sevim Karaçorlu | |||
P2860 | cites work | Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality | Q24530412 |
Epidemiological trends in nosocomial candidemia in intensive care | Q25255762 | ||
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study | Q29616607 | ||
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Par | Q30453440 | ||
Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance | Q30994297 | ||
Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. | Q34680777 | ||
Candida parapsilosis, an emerging fungal pathogen | Q34852747 | ||
Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods. | Q35073614 | ||
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage | Q37032961 | ||
Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital | Q37576521 | ||
Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility | Q37613000 | ||
The epidemiology of candidemia in two United States cities: results of a population-based active surveillance | Q41696774 | ||
In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance | Q42222929 | ||
High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility. | Q43250363 | ||
Epidemiology of candidemia in oncology patients: a 6-year survey in a Portuguese central hospital | Q43297951 | ||
Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection | Q43438479 | ||
Attributable mortality of nosocomial candidemia, revisited | Q44386169 | ||
Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies | Q44913001 | ||
High frequency of Candida parapsilosis on the hands of healthy hosts | Q45202625 | ||
Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. | Q50700185 | ||
Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004 | Q60639244 | ||
Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unit | Q60639245 | ||
Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional Study | Q61833672 | ||
Rising Incidence of Candida parapsilosis Fungemia in Patients with Hematologic Malignancies: Clinical Aspects, Predisposing Factors, and Differential Pathogenicity of the Causative Strains | Q63762171 | ||
Nosocomial acquisition of Candida albicans: an epidemiologic study | Q70770545 | ||
Fungal sepsis: multisite colonization versus fungemia | Q72765075 | ||
The epidemiology of hematogenous candidiasis caused by different Candida species | Q73441200 | ||
Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia | Q79803990 | ||
Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: emergence of Candida parapsilosis | Q80374897 | ||
Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study | Q80382945 | ||
Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital | Q82504322 | ||
P433 | issue | 4 | |
P921 | main subject | Candida parapsilosis | Q144068 |
fungemia | Q3491700 | ||
P1104 | number of pages | 6 | |
P304 | page(s) | 263-268 | |
P577 | publication date | 2010-06-04 | |
P1433 | published in | Mycopathologia | Q15763210 |
P1476 | title | Increase in Candida parapsilosis fungemia in critical care units: a 6-years study | |
P478 | volume | 170 |
Q38511946 | Antifungal drug resistance among Candida species: mechanisms and clinical impact |
Q43595310 | Aspartyl proteinase, phospholipase, esterase and hemolysin activities of clinical isolates of the Candida parapsilosis species complex |
Q38233262 | Candidaemia observed at a university hospital in Milan (northern Italy) and review of published studies from 2010 to 2014. |
Q42680559 | Candidemia in non-ICU surgical wards: Comparison with medical wards. |
Q34528210 | Catheter-related Candida bloodstream infection in intensive care unit patients: a subgroup analysis of the China-SCAN study |
Q46484431 | Characterization of the Candida parapsilosis complex in East China: species distribution differs among cities |
Q41544911 | Distribution of yeast isolates from invasive infections and their in vitro susceptibility to antifungal agents: evidence from 299 cases in a 3-year (2010 to 2012) surveillance study |
Q36898053 | Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project) |
Q40276130 | Epidemiology, species distribution, clinical characteristics and mortality of candidaemia in a tertiary care university hospital in Turkey, 2007-2014. |
Q39322474 | Fungemia caused by Candida species in a children's public hospital in the city of São Paulo, Brazil: study in the period 2007-2010. |
Q60923177 | Increase in Candida parapsilosis candidemia in cancer patients |
Q35363662 | Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France |
Search more.